F5 (NASDAQ: FFIV) EVP Okeke logs RSU vesting and common share sale

Rhea-AI Filing Summary

F5, Inc. executive Angelique M. Okeke reported equity compensation activity, showing restricted stock units vesting into common shares and a related share disposition on February 1, 2026. As EVP and General Counsel, she acquired 821 shares of common stock at $0 upon vesting of service-based RSU awards, bringing her directly owned common stock to 2,612 shares before a disposition.

The filing also reports a disposition of 352 common shares at $275.61 per share, leaving 2,260 common shares owned directly after the transaction. Several RSU grants converted into common stock at no cost, with remaining RSU balances that continue to vest in scheduled quarterly and specific-date installments, conditioned on her continued service to F5.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OKEKE ANGELIQUE M

(Last) (First) (Middle)

C/O F5, INC.

801 5TH AVENUE

(Street)

SEATTLE WA 98104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/01/2026		M		821(1)	A	$0	2,612	D
Common Stock	02/01/2026		F		352	D	$275.61	2,260	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(2)	$0	02/01/2026		M			113	(3)	(4)	Common Stock	113	$0	340	D
Restricted Stock Unit(2)	$0	02/01/2026		M			375	(5)	(4)	Common Stock	375	$0	3,377	D
Restricted Stock Unit(2)	$0	02/01/2026		M			333	(6)	(4)	Common Stock	333	$0	3,674	D

Explanation of Responses:

1. Shares acquired upon the vesting of May 1, 2024, November 1, 2024, and November 3, 2025 awards of service-based Restricted Stock Units.

2. Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.

3. The service-based Restricted Stock Units (RSUs) outstanding under this November 1, 2024 grant vest as follows: 113 vest May 1, 2025, 113 vest August 1, 2025, 114 vest November 1, 2025, 113 vest February 1, 2026, 113 vest May 1, 2026, 113 vest August 1, 2026, and 114 vest November 1, 2026.

4. If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

5. This May 1, 2024 award of service-based Restricted Stock Units vests 25% on May 1, 2025, with the remaining balance vesting in twelve equal quarterly increments beginning August 1, 2025 until the award is fully vested on May 1,2028.

6. This November 3, 2025 award of service-based Restricted Stock Units vests in twelve equal quarterly increments beginning February 1, 2026.

Remarks:

	/s/ Angelique M. Okeke	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did F5 (FFIV) EVP Angelique Okeke report in this Form 4?

She reported vesting of restricted stock units into F5 common stock and a related share disposition on February 1, 2026. The transactions reflect routine equity compensation activity tied to prior RSU awards and her ongoing service as EVP and General Counsel.

How many F5 (FFIV) common shares did Angelique Okeke acquire and dispose of?

She acquired 821 F5 common shares at $0 upon RSU vesting and disposed of 352 common shares at $275.61 per share. After these transactions, she directly held 2,260 shares of F5 common stock according to the reported balances.

What restricted stock unit (RSU) activity did FFIV disclose for Angelique Okeke?

Multiple RSU grants converted into F5 common stock at a $0 exercise price on February 1, 2026, including tranches of 113, 375, and 333 units. Each RSU represents a contingent right to receive one share of F5 common stock on its vesting date.

What ongoing vesting schedule applies to Angelique Okeke’s F5 (FFIV) RSUs?

One November 1, 2024 RSU grant vests in specific installments through November 1, 2026, while a May 1, 2024 grant vests 25% on May 1, 2025 and then quarterly until May 1, 2028. A November 3, 2025 grant vests in twelve equal quarterly installments from February 1, 2026.

What conditions must be met for Angelique Okeke’s F5 RSUs to vest?

The RSUs vest only if she continues providing services to F5 through each vesting date. When a vesting condition is met, the corresponding number of F5 common shares is issued to her on the applicable vest date under the grant terms.

What is Angelique Okeke’s role at F5 (FFIV) in this insider filing?

She is identified as an officer of F5, serving as Executive Vice President and General Counsel. The Form 4 reflects equity compensation transactions in her capacity as a senior executive, including RSU vesting into common stock and a disposition of common shares.